<bill session="109" type="h" number="5993" updated="2023-01-12T17:52:33Z">
  <state datetime="2006-07-28">REFERRED</state>
  <status>
    <introduced datetime="2006-07-28"/>
  </status>
  <introduced datetime="2006-07-28"/>
  <titles>
    <title type="display">To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.</title>
  </titles>
  <sponsor bioguide_id="E000172"/>
  <cosponsors>
    <cosponsor bioguide_id="B000420" joined="2006-07-28"/>
    <cosponsor bioguide_id="B001236" joined="2006-07-28"/>
    <cosponsor bioguide_id="M001140" joined="2006-07-28"/>
    <cosponsor bioguide_id="W000119" joined="2006-07-28"/>
  </cosponsors>
  <actions>
    <action datetime="2006-07-28">
      <text>Introduced in House</text>
    </action>
    <action datetime="2006-07-28" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2006-08-01">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="109" type="s" number="3695" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Commerce"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Generic drugs"/>
  </subjects>
  <amendments/>
  <summary date="2006-09-20T18:04:19Z" status="Introduced in House">Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from manufacturing, marketing, selling, or distributing a generic version of such drug during any exclusivity period granted to manufacturers of generic brands.</summary>
</bill>
